Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
11
Named actors
12
Disclosed $ (bull / bear)
$5.0M / $925K
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-07-29 | 5%+ holder (13G) BlackRock, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) KAREN WALKER | filed notice to sell | $95K | SEC ↗ |
| 2026-04-14 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) KAREN WALKER | filed notice to sell | $23K | SEC ↗ |
| 2026-04-07 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) DANIEL SPIEGELMAN | filed notice to sell | $163K | SEC ↗ |
| 2026-04-02 | Issuer (share issuance) | priced an offering | — |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-03-31 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) DANIEL SPIEGELMAN | filed notice to sell | $140K | SEC ↗ |
| 2025-12-18 | 10% owner / other Westlake BioPartners Opportunity Fund I, L.P. | bought | $1000K | SEC ↗ |
| 2025-12-18 | 10% owner / other Westlake BioPartners Fund I, L.P. | bought | $1000K | SEC ↗ |
| 2025-12-18 | 10% owner / other Westlake BioPartners GP I, LLC | bought | $1000K | SEC ↗ |
| 2025-12-18 | 10% owner / other Westlake BioPartners Opportunity GP I, LLC | bought | $1000K | SEC ↗ |
| 2025-12-18 | Director SEIDENBERG BETH C | bought | $1000K | SEC ↗ |
| 2025-12-18 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2025-12-15 | Chief Technology Officer Walker Karen Marie | sold | $293K | SEC ↗ |
| 2025-12-15 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2025-12-15 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) KAREN WALKER | filed notice to sell | $211K | SEC ↗ |
| 2025-12-04 | Director Beth Seidenberg, M.D | adopted a selling plan | — | SEC ↗ |
| 2025-12-02 | Chief Executive Officer Warner Biddle | adopted a selling plan | — | SEC ↗ |
| 2025-11-17 | 5%+ holder (13G) GordonMD Global Investments LP | disclosed a passive stake (13G) | — | SEC ↗ |